Fabmid develops a cutting-edge DNA vector to reduce the cost and improve efficiency of gene therapy. Our non-viral vector is both easy to produce (cheap and scalable process) and has all the properties required from a safe and efficient vector: high cell transfection efficiency, low toxicity, high stability and selectivity.

Restez informés sur l’actualité de Paris-Saclay SPRING 2019 !

* Requis